IFNA1 and COVID-19: Intriguingly, a recent longitudinal analysis showed that plasma IFN-α was sustained at high levels in patients with severe COVID-19, whereas IFN-α levels declined in those with moderate COVID-19 during their clinical course.23 Therefore, further studies are needed to understand the exact role of type I IFN in the pathogenesis of COVID-19.